Tatva Chintan shares hit another 52-week high after reporting highest-ever quarterly turnover

Tatva Chintan Pharma said that it foresees the revenue trend growth with similar momentum over the next quarters and EBITDA margin.

Leave a Reply

Your email address will not be published. Required fields are marked *